Place : Austria, Wien
Contact Person:Rosemarie Liberman
Description:The past few years have witnessed significant improvements in our understanding of lymphoproliferative malignancies and in our capabilities to treat patients diagnosed with these diseases. The introduction of new agents, including small molecules, non-conjugated and conjugated antibodies, and immunomodulation technologies (particularly chimeric antigen receptor T cells) has considerably changed the landscape of lymphoproliferative malignancies, with most patients achieving at least a durable response and even cure. The scientific program of the upcoming congress covers topics from all fields of clinical and laboratory aspects of chronic lymphocytic leukemia and lymphoma. World leaders in these fields will take part in this meeting and address new diagnostic technologies, current and future therapies. A special session will also be provided by leading experts in CAR T cells.
Deadline for abstracts/proposals : 24th February 2020
Organized By :Bioevents
Keynote Speakers :
Venue :Radisson Blu Park Royal Palace Hotel Schlossallee 8 Vienna,1140
Check the event website for more details.